Electrical Stimulation Versus Coronary Artery Bypass Surgery in Severe Angina Pectoris

Author:

Mannheimer Clas1,Eliasson Tore1,Augustinsson Lars-Erik1,Blomstrand Christian1,Emanuelsson Håkan1,Larsson Sture1,Norrsell Henrik1,Hjalmarsson Åke1

Affiliation:

1. From the Multidisciplinary Pain Centre (C.M., T.E., H.N.), Department of Medicine, Östra Hospital and the Departments of Neurosurgery (L.-E.A.), Neurology (C.B.), Cardiology (H.E., A.H.), and Thoracic Surgery (S.L.), Sahlgren’s Hospital, Gothenburg, Sweden.

Abstract

Background —Spinal cord stimulation (SCS) has been shown to have antianginal and anti-ischemic effects in severe angina pectoris. The present study was performed to investigate whether SCS can be used as an alternative to coronary artery bypass grafting (CABG) in selected patient groups, ie, patients with no proven prognostic benefit from CABG and with an increased surgical risk. Methods and Results —One hundred four patients were randomized (SCS, 53; CABG, 51). The patients were assessed with respect to symptoms, exercise capacity, ischemic ECG changes during exercise, rate-pressure product, mortality, and cardiovascular morbidity before and 6 months after the operation. Both groups had adequate symptom relief ( P <.0001), and there was no difference between SCS and CABG. The CABG group had an increase in exercise capacity ( P =.02), less ST-segment depression on maximum ( P =.005) and comparable ( P =.0009) workloads, and an increase in the rate-pressure product both at maximum ( P =.0003) and comparable ( P =.03) workloads compared with the SCS group. Eight deaths occurred during the follow-up period, 7 in the CABG group and 1 in the SCS group. On an intention-to-treat basis, the mortality rate was lower in the SCS group ( P =.02). Cerebrovascular morbidity was also lower in the SCS group ( P =.03). Conclusions —CABG and SCS appear to be equivalent methods in terms of symptom relief in this group of patients. Effects on ischemia, morbidity, and mortality should be considered in the choice of treatment method. Taking all factors into account, it seems reasonable to conclude that SCS may be a therapeutic alternative for patients with an increased risk of surgical complications.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 251 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3